TY - JOUR
T1 - When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development?
T2 - A Systematic Review of NICE Guidance
AU - Longworth, Louise
AU - Youn, Jihee
AU - Bojke, Laura
AU - Palmer, Stephen
AU - Griffin, Susan
AU - Spackman, Eldon
AU - Claxton, Karl
PY - 2013/2
Y1 - 2013/2
N2 - There is growing interest internationally in linking reimbursement decisions with recommendations for further research. In the UK, the National Institute for Health and Clinical Excellence (NICE) can issue guidance to approve the routine use of a health intervention, reject routine use or recommend use within a research programme. These latter recommendations have restricted use to 'only in research' (OIR) or have recommended further research alongside routine use ('approval with research' or AWR). However, it is not currently clear when such recommendations are likely to be made.
AB - There is growing interest internationally in linking reimbursement decisions with recommendations for further research. In the UK, the National Institute for Health and Clinical Excellence (NICE) can issue guidance to approve the routine use of a health intervention, reject routine use or recommend use within a research programme. These latter recommendations have restricted use to 'only in research' (OIR) or have recommended further research alongside routine use ('approval with research' or AWR). However, it is not currently clear when such recommendations are likely to be made.
UR - https://www.scopus.com/pages/publications/84876266455
U2 - 10.1007/s40273-012-0013-6
DO - 10.1007/s40273-012-0013-6
M3 - Article
C2 - 23329429
SN - 1170-7690
VL - 31
SP - 137
EP - 149
JO - Pharmacoeconomics
JF - Pharmacoeconomics
IS - 2
ER -